The BCR-ABL assay can be used to monitor minimal residual disease in Phildelphia chromosome positive CML or AML patients being treated with tyrosine kinase inhibitors (TKI).
Additional Test Information
EDTA Bone Marrow (lavender top) or EDTA Whole Blood (lavender top) or Total RNA
Additional Sample Requirements
Sample must be received within 48 hours of collection. Indicate on specimen tube and requisition whether sample is whole blood or bone marrow.
3-5 ml EDTA Bone Marrow (lavender top) or 10 ml EDTA Whole Blood (lavender top)